10-K Filing

APPLIED BIOSCIENCES CORP. CIK: 1607549 FY 2018

Filing Information

Form Type	10-K
Accession Number	`0001477932-19-003830`
Period End Date	20190331
Filing Date	20190701
Fiscal Year	2018
Fiscal Period	FY
XBRL Instance	appb-20190331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 44 Cash Flow Statement 68 Stockholders Equity 21

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash	`Cash`	$60.93K	USD	Point-in-time
Cash	`Cash`	$47.04K	USD	Point-in-time
Cash	`Cash`	$212.64K	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$163.41K	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$12.39K	USD	Point-in-time
Inventory	`InventoryNet`	$78.74K	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventory	`InventoryNet`	$29.07K	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Prepaids and other current assets	`OtherPrepaidExpenseCurrent`	$65.27K	USD	Point-in-time
Prepaids and other current assets	`OtherPrepaidExpenseCurrent`	$124.45K	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$226.85K	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$354.46K	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	13.40M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.44K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$452.05K	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	10.50M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	13.40M	shares	Point-in-time
Equity investments	`EquityMethodInvestments`	$898.29K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	10.50M	shares	Point-in-time
Equity investments	`EquityMethodInvestments`	$468.54K	USD	Point-in-time
Common stock shares to be issued	`CommonStockSharesToBeIssued`	263,000.00	shares	Point-in-time
Goodwill	`Goodwill`	$1.94M	USD	Point-in-time
Goodwill	`Goodwill`	-	USD	Point-in-time
Goodwill	`Goodwill`	$1.94M	USD	Point-in-time
Common stock shares to be issued	`CommonStockSharesToBeIssued`	408,805.00	shares	Point-in-time
Other asset	`OtherAssetsNoncurrent`	$5.50K	USD	Point-in-time
Other asset	`OtherAssetsNoncurrent`	$5.50K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.65M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$705.33K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$21.85K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$278.55K	USD	Point-in-time
Note Payable	`NotesPayable`	-	USD	Point-in-time
Note Payable	`NotesPayable`	$25.00K	USD	Point-in-time
Note Payable	`NotesPayable`	$-25.00K	USD	Point-in-time
Accrued expenses	`OtherAccountsPayableAndAccruedLiabilities`	$70.72K	USD	Point-in-time
Accrued expenses	`OtherAccountsPayableAndAccruedLiabilities`	$14.04K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$35.88K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$374.27K	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock; $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding at March 31, 2019 and 2018	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding at March 31, 2019 and 2018	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.00001 par value; 200,000,000 shares authorized; 13,397,110 and 10,499,610 issued and outstanding at March 31, 2019 and 2018, respectively	`CommonStockValue`	$135.00	USD	Point-in-time
Common stock; $0.00001 par value; 200,000,000 shares authorized; 13,397,110 and 10,499,610 issued and outstanding at March 31, 2019 and 2018, respectively	`CommonStockValue`	$105.00	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$6.89M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$3.05M	USD	Point-in-time
Common stock to be issued, 408,805 and 263,000 shares at March 31, 2019 and 2018, respectively	`CommonStockToBeIssued238000And263000SharesAtJune302018UnauditedAndMarch312018Respectively`	$773.81K	USD	Point-in-time
Common stock to be issued, 408,805 and 263,000 shares at March 31, 2019 and 2018, respectively	`CommonStockToBeIssued238000And263000SharesAtJune302018UnauditedAndMarch312018Respectively`	$526.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.90M	USD	Point-in-time
Total Applied BioSciences Corp. Stockholders' Equity	`StockholdersEquity`	$2.13M	USD	Point-in-time
Total Applied BioSciences Corp. Stockholders' Equity	`StockholdersEquity`	$678.47K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-9.03K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$1.14M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.28M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.64M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$669.44K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.65M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$705.33K	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Products	`Products`	$543.97K	USD	Annual
Products	`Products`	$197.55K	USD	Annual
Services	`Services`	-	USD	Annual
Services	`Services`	$163.09K	USD	Annual
Total revenues, net	`Revenues`	$707.06K	USD	Annual
Total revenues, net	`Revenues`	$197.55K	USD	Annual
Products	`CostOfProducts`	$498.99K	USD	Annual
Products	`CostOfProducts`	$155.55K	USD	Annual
Services	`CostOfService`	$22.78K	USD	Annual
Services	`CostOfService`	-	USD	Annual
Total costs of revenue	`CostOfRevenue`	$155.55K	USD	Annual
Total costs of revenue	`CostOfRevenue`	$521.77K	USD	Annual
GROSS MARGIN	`GrossProfit`	$42.01K	USD	Annual
GROSS MARGIN	`GrossProfit`	$185.29K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$356.95K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$698.18K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$2.09M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$953.48K	USD	Annual
Depreciation and Amortization	`DepreciationAndAmortization`	$224.77K	USD	Annual
Depreciation and Amortization	`DepreciationAndAmortization`	$40.63K	USD	Annual
Impairment of asset	`AssetImpairmentCharges`	-	USD	Annual
Impairment of asset	`AssetImpairmentCharges`	$893.67K	USD	Annual
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$2.43M	USD	Annual
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$2.83M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-2.39M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-2.65M	USD	Annual
Change in fair value of equity investments	`ChangeInFairValueOfEquityInvestments`	$429.75K	USD	Annual
Change in fair value of equity investments	`ChangeInFairValueOfEquityInvestments`	-	USD	Annual
Dividend received from equity investment	`ProceedsFromDividendsReceived`	-	USD	Annual
Dividend received from equity investment	`ProceedsFromDividendsReceived`	$186.40K	USD	Annual
Interest Expense	`InterestExpense`	-	USD	Annual
Interest Expense	`InterestExpense`	$648.88K	USD	Annual
Total other (expense), net	`OtherNonoperatingIncomeExpense`	$-32.72K	USD	Annual
Total other (expense), net	`OtherNonoperatingIncomeExpense`	-	USD	Annual
NET LOSS	`NetIncomeLoss`	$-2.39M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-2.68M	USD	Annual
Less: Net loss (income) attributable to non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-10.76K	USD	Annual
Less: Net loss (income) attributable to non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-49.70K	USD	Annual
NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP.	`ProfitLoss`	$-2.63M	USD	Annual
NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP.	`ProfitLoss`	$-2.38M	USD	Annual
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	Annual
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.16	USD	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	11.91M	shares	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.07M	shares	Annual

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.39M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.68M	USD	Annual
Change in fair value of equity investments	`UnrealizedGainLossOnInvestments`	$429.75K	USD	Annual
Change in fair value of equity investments	`UnrealizedGainLossOnInvestments`	-	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$500.27K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Fair value of shares issued for services	`FairValueOfSharesIssuedToConsultants`	$346.80K	USD	Annual
Fair value of shares issued for services	`FairValueOfSharesIssuedToConsultants`	$232.78K	USD	Annual
Fair value of shares issued to officers and directors	`FairValueOfSharesIssuedToOfficersAndBoard`	$375.00K	USD	Annual
Fair value of shares issued to officers and directors	`FairValueOfSharesIssuedToOfficersAndBoard`	$1.06M	USD	Annual
Depreciation	`Depreciation`	$258.00	USD	Annual
Depreciation	`Depreciation`	$40.63K	USD	Annual
Amortization of intangible	`AmortizationOfIntangibleAssets`	$224.51K	USD	Annual
Amortization of intangible	`AmortizationOfIntangibleAssets`	-	USD	Annual
Impairment of asset	`AssetImpairmentCharges`	-	USD	Annual
Impairment of asset	`AssetImpairmentCharges`	$893.67K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-23.02K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-6.71K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-49.66K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-6.38K	USD	Annual
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.47K	USD	Annual
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$294.07K	USD	Annual
Other asset	`IncreaseDecreaseInOtherOperatingAssets`	$-5.50K	USD	Annual
Other asset	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$35.89K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$4.30K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-673.47K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-905.05K	USD	Annual
Cash paid for business acquisition, net of cash acquired	`PaymentsForDepositsOnRealEstateAcquisitions`	-	USD	Annual
Cash paid for business acquisition, net of cash acquired	`PaymentsForDepositsOnRealEstateAcquisitions`	$711.74K	USD	Annual
Acquisition of equity investments	`PaymentsToAcquireBusinessesAndInterestInAffiliates`	-	USD	Annual
Acquisition of equity investments	`PaymentsToAcquireBusinessesAndInterestInAffiliates`	$-168.54K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.55K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.70K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-173.24K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-713.29K	USD	Annual
Repurchase of shares previously issued	`PaymentsForRepurchaseOfSharesPreviouslyIssued`	$-100.00K	USD	Annual
Repurchase of shares previously issued	`PaymentsForRepurchaseOfSharesPreviouslyIssued`	-	USD	Annual
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$1.53M	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$795.00K	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$75.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$695.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.60M	USD	Annual
NET CHANGE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-151.70K	USD	Annual
NET CHANGE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-13.89K	USD	Annual
CASH, BEGINNING OF PERIOD	`Cash`	$60.93K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`Cash`	$47.04K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`Cash`	$212.64K	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	$60.93K	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	$47.04K	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	$212.64K	USD	Point-in-time
Fair value of common stock issued upon conversion of convertible notes and accrued interest	`FairValueOfCommonStockIssuedUponConversionOfConvertibleNotes`	-	USD	Annual
Fair value of common stock issued upon conversion of convertible notes and accrued interest	`FairValueOfCommonStockIssuedUponConversionOfConvertibleNotes`	$1.60M	USD	Annual
Fair value of shares issued to consultants recorded as prepaid	`FairValueOfSharesIssuedToConsultantsRecordedAsPrepaid`	$109.00K	USD	Annual
Fair value of shares issued to consultants recorded as prepaid	`FairValueOfSharesIssuedToConsultantsRecordedAsPrepaid`	$4.17K	USD	Annual
Current assets	`CurrentAsset`	-	USD	Annual
Current assets	`CurrentAsset`	$401.15K	USD	Annual
Fixed assets	`FixedAssets`	$486.68K	USD	Annual
Fixed assets	`FixedAssets`	-	USD	Annual
Costs in excess of net assets acquired	`CostsInExcessOfNetAssetsAcquired`	$1.94M	USD	Annual
Costs in excess of net assets acquired	`CostsInExcessOfNetAssetsAcquired`	-	USD	Annual
Current liabilities assumed	`CurrentLiabilitiesAssumed`	$-353.00K	USD	Annual
Current liabilities assumed	`CurrentLiabilitiesAssumed`	-	USD	Annual
Notes payable assumed	`NotesPayableAssumed`	$-25.00K	USD	Annual
Notes payable assumed	`NotesPayableAssumed`	-	USD	Annual
Non controlling interest	`NonControllingInterest`	$-1.20M	USD	Annual
Non controlling interest	`NonControllingInterest`	-	USD	Annual

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.28M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.64M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$669.44K	USD	Point-in-time
Issuance of common stock previously committed but not issued, Amount	`IssuanceOfCommonStockPreviouslyCommittedButNotIssuedAmount`	-	USD	Annual
Issuance of common stock previously committed but not issued, Amount	`IssuanceOfCommonStockPreviouslyCommittedButNotIssuedAmount`	-	USD	Annual
Issuance of common stock for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	$795.00K	USD	Annual
Issuance of common stock for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	$75.00K	USD	Annual
Shares repurchased for cash and cancelled, amount	`SharesRepurchasedForCashAndCancelledAmount`	$-100.00K	USD	Annual
Fair value of shares issued for services, amount	`StockIssuedDuringPeriodValueIssuedForServices`	$346.80K	USD	Annual
Fair value of shares issued for services, amount	`StockIssuedDuringPeriodValueIssuedForServices`	$341.78K	USD	Annual
Shares issued to Company's CEO, amount	`SharesIssuedToCompanysCeoAmount`	$375.00K	USD	Annual
Fair value of shares issued to Company officers and directors, amount	`FairValueOfSharesIssuedToCompanyOfficersAndDirectorsAmount`	$1.06M	USD	Annual
Beneficial conversion feature associated with issuance of convertible notes	`DebtInstrumentConvertibleBeneficialConversionFeature`	$500.27K	USD	Annual
Shares issued for acquisition of Trace Analytics, Inc., amount	`SharesIssuedForAcquisitionOfTraceAnalyticsInc.Amount`	$500.00K	USD	Annual
Non-controlling interest recognized upon acquisition of Trace Analytics	`NoncontrollingInterestRecognizedUponAcquisitionOfTraceAnalytics`	$1.20M	USD	Annual
Shares issued upon conversion of convertible notes, amount	`SharesIssuedUponConversionOfConvertibleNotesAmount`	$1.60M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-2.39M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-2.68M	USD	Annual
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.28M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.64M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$669.44K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.